The University of Chicago Header Logo

Connection

Carrie W. Rinker-Schaeffer to Tumor Cells, Cultured

This is a "connection" page, showing publications Carrie W. Rinker-Schaeffer has written about Tumor Cells, Cultured.
  1. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clin Exp Metastasis. 2012 Jun; 29(5):397-408.
    View in: PubMed
    Score: 0.088
  2. In vitro metastatic colonization of human ovarian cancer cells to the omentum. Clin Exp Metastasis. 2010 Mar; 27(3):185-96.
    View in: PubMed
    Score: 0.077
  3. Inhibition of prostate cancer metastatic colonization by approximately 4.2 Mb of human chromosome 12. Int J Cancer. 2004 Jan 01; 108(1):15-22.
    View in: PubMed
    Score: 0.050
  4. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res. 2002 Nov 15; 62(22):6717-23.
    View in: PubMed
    Score: 0.046
  5. The Dunning model. Prostate. 2000 Jun 01; 43(4):295-302.
    View in: PubMed
    Score: 0.039
  6. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 1999 Nov 01; 59(21):5483-7.
    View in: PubMed
    Score: 0.037
  7. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res. 1998 Nov 01; 58(21):4963-9.
    View in: PubMed
    Score: 0.035
  8. Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential. Clin Cancer Res. 1998 Oct; 4(10):2391-8.
    View in: PubMed
    Score: 0.035
  9. Identification of a novel metastasis-suppressor region on human chromosome 12. Cancer Res. 1998 Aug 15; 58(16):3561-5.
    View in: PubMed
    Score: 0.034
  10. Localization of prostate cancer metastasis-suppressor activity on human chromosome 17. Prostate. 1997 Dec 01; 33(4):271-80.
    View in: PubMed
    Score: 0.033
  11. Development of a high-efficiency method for gene marking of Dunning prostate cancer cell lines with the enzyme beta-galactosidase. Prostate. 1996 Jul; 29(1):60-4.
    View in: PubMed
    Score: 0.030
  12. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res. 1994 Dec 01; 54(23):6249-56.
    View in: PubMed
    Score: 0.027
  13. Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer. 1993 Nov 11; 55(5):841-7.
    View in: PubMed
    Score: 0.025
  14. Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med. 2001 Jun; 45(6):1046-55.
    View in: PubMed
    Score: 0.010
  15. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn Reson Med. 2000 May; 43(5):633-9.
    View in: PubMed
    Score: 0.010
  16. In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer. Urology. 1999 Sep; 54(3):573-7.
    View in: PubMed
    Score: 0.009
  17. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer. Cancer Chemother Pharmacol. 1999; 44(1):81-7.
    View in: PubMed
    Score: 0.009
  18. Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells. Cancer Res. 1998 Oct 15; 58(20):4572-6.
    View in: PubMed
    Score: 0.009
  19. Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemother Pharmacol. 1998; 41(6):505-12.
    View in: PubMed
    Score: 0.008
  20. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995 May 12; 268(5212):884-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.